iRhythm Technologies, Inc. (IRTC) |
|
88 3.04 (3.58%)
|
09-27 10:34 |
|
Open: |
85.42 |
Pre. Close: |
84.96 |
|
High:
|
88 |
Low:
|
85.015 |
|
Volume:
|
75,699 |
Market Cap:
|
2,691(M) |
|
|
|
Technical analysis |
as of: 2023-09-27 10:17:27 AM |
|
Short-term rate:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
|
Mid-term rate:
|
 |
| Target: |
Six months: 115.51 One year: 127.34 |
| Support: |
Support1: 82.51 Support2: 68.64 |
| Resistance: |
Resistance1: 98.89 Resistance2: 109.02 |
| Pivot: |
91.83  |
| Moving Average: |
MA(5): 85.97 MA(20): 94.44
MA(100): 106.12 MA(250): 109.94 |
| MACD: |
MACD(12,26): -5 Signal(9): -4.3 |
| Stochastic oscillator: |
%K(14,3): 17.2 %D(3): 11.4 |
| RSI: |
RSI(14): 34.8 |
| 52-week: |
High: 140.23 Low: 82.51 |
| Average Vol(K): |
3-Month: 339 (K) 10-Days: 334 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ IRTC ] has closed above bottom band by 26.1%. Bollinger Bands are 18.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
85.96 - 86.78 |
86.78 - 87.28 |
|
Low:
|
80.9 - 81.98 |
81.98 - 82.63 |
|
Close:
|
83.71 - 85.49 |
85.49 - 86.56 |
|
Company Description |
|
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California. |
Headline News |
Wed, 27 Sep 2023
iRhythm Technologies, Inc. (NASDAQ:IRTC) Receives Average ... - MarketBeat
Tue, 26 Sep 2023
iRhythm Launches Next Generation Zio Monitor and Enhanced Zio Service: Its Smallest, Lightest and Thinnest Cardiac Monitor - Yahoo Finance
Mon, 25 Sep 2023
Notable Monday Option Activity: SRCL, IRTC, ZS - Nasdaq
Fri, 22 Sep 2023
Unveiling iRhythm Technologies (IRTC)'s Value: Is It Really Priced ... - GuruFocus.com
Thu, 21 Sep 2023
iRhythm Technologies is Now Oversold (IRTC) - Nasdaq
Mon, 18 Sep 2023
Duality Advisers LP Reduces Holdings in iRhythm Technologies, Inc ... - MarketBeat
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
31 (M) |
| Shares Float |
30 (M) |
|
% Held by Insiders
|
0.7 (%) |
|
% Held by Institutions
|
112.6 (%) |
|
Shares Short
|
2,330 (K) |
|
Shares Short P.Month
|
2,210 (K) |
Stock Financials |
|
EPS
|
-3.19 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
7.32 |
|
Profit Margin (%)
|
-22 |
|
Operating Margin (%)
|
-22.2 |
|
Return on Assets (ttm)
|
-14.5 |
|
Return on Equity (ttm)
|
-42.4 |
|
Qtrly Rev. Growth
|
21.6 |
|
Gross Profit (p.s.)
|
9.2 |
|
Sales Per Share
|
14.78 |
|
EBITDA (p.s.)
|
-2.84 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-19 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
-27.41 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
11.88 |
|
Price to Sales
|
5.89 |
|
Price to Cash Flow
|
-139.68 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
